By SkinCareSupplements.com Research & Editorial Team | Last updated: September 2026
How We Find, Evaluate, and Report Research
This page explains exactly how SkinCareSupplements.com identifies, assesses, and presents the clinical research featured on this site. Transparency about our methods allows you to evaluate the quality and limitations of our work.
Step 1: Study Identification
We identify relevant studies through systematic searches of recognized research databases and repositories, including:
- PubMed / MEDLINE (National Library of Medicine)
- ClinicalTrials.gov (U.S. National Library of Medicine trial registry)
- Cochrane Library (systematic reviews and meta-analyses)
- Google Scholar (broad academic search)
- EFSA Scientific Opinions (European Food Safety Authority)
- Institutional and university dermatology research repositories
- Regulatory filings and safety databases (FDA, WHO)
We prioritize studies that:
- Have been published in peer-reviewed journals
- Involve human participants (when available)
- Study ingredients commonly found in oral supplements marketed for skin, hair, or nail health
- Measure clinically relevant skin health outcomes (hydration, elasticity, wrinkle depth, barrier function, pigmentation, hair density, nail strength)
- Have clearly described methodology, outcomes, and funding
Step 2: Study Selection Criteria
Not every published study meets our threshold for inclusion. We apply the following selection criteria:
| Criterion | Included | Excluded or Flagged |
|---|---|---|
| Publication status | Published in a peer-reviewed journal | Preprints without peer review (flagged if cited for emerging context) |
| Study subjects | Human participants | Animal or in-vitro only (included only as mechanistic context, clearly labeled) |
| Delivery method | Oral supplementation | Topical-only studies (excluded unless directly compared with oral delivery) |
| Outcome measures | Clinically relevant skin, hair, or nail endpoints | Only biomarker changes without clinical correlation |
| Methodology disclosure | Fully described methods and statistical analysis | Insufficient methodological detail to assess quality |
| Conflicts of interest | Disclosed funding and author relationships | Undisclosed funding (flagged; study may still be cited with this noted) |
Step 3: Quality Assessment
Before including a study in our coverage, we assess its quality across multiple dimensions:
Study Quality Assessment Framework
| Study Design | Is this an RCT, observational study, case report, or preclinical research? The design type determines what conclusions can and cannot be drawn about a supplement ingredient. |
| Sample Size | How many participants were included? Many skin supplement studies use small samples (under 100), which increases the likelihood that results will not replicate. |
| Population | Who was studied? Age, skin type, health status, geographic location, and baseline skin condition affect whether findings apply to a broader population. |
| Controls | Was there a placebo control group? Was the study blinded? Double-blind, placebo-controlled designs produce more reliable results than open-label trials. |
| Duration | How long did the study last? Skin supplement studies often run 8 to 12 weeks; shorter durations may miss effects that require longer supplementation periods. |
| Outcomes | What was actually measured? Were the outcomes assessed with validated instruments (e.g., Cutometer for elasticity, corneometry for hydration) or self-reported questionnaires? |
| Dose and Form | What specific form and dose of the ingredient was used? Results from 5g of hydrolyzed collagen peptides may not apply to 1g of a different collagen type. |
| Conflicts | Who funded the study? Do the authors have financial ties to the ingredient or product manufacturer? Manufacturer-funded studies are not automatically invalid but require additional scrutiny. |
| Replication | Have other independent researchers found similar results? Single unreplicated studies, even well-designed ones, are inherently less reliable. |
Step 4: Evidence Classification
For each ingredient and specific health claim, we assess the overall body of evidence and classify it into one of four levels:
| Classification | Criteria | What It Means for You |
|---|---|---|
| Strong | Multiple well-designed RCTs or at least one high-quality meta-analysis with consistent positive findings in relevant populations | The research consistently supports this claim, though individual results may still vary |
| Moderate | Several human studies showing generally positive results, but with some inconsistency in findings, smaller sample sizes, or methodological limitations | There is meaningful research support, but the evidence is not yet definitive |
| Preliminary | Limited human data from early-stage or small trials, pilot studies, or findings primarily supported by preclinical research | Early results are interesting but not sufficient to draw reliable conclusions |
| Insufficient | Too few human studies, conflicting results that cannot be reconciled, or only animal and cell-culture data available | There is not enough quality research to assess whether this claim is supported |
These classifications represent our editorial assessment of published evidence at the time of review. They are not regulatory determinations. A “Strong” classification does not mean the FDA has approved the claim, and an “Insufficient” classification does not mean the ingredient is ineffective — only that the published evidence is not adequate to make a determination.
Step 5: Handling Conflicting Evidence
Research on skin supplement ingredients frequently produces conflicting results. When studies disagree, we:
- Report the conflict transparently — We present both positive and negative findings rather than selecting only studies that support a particular conclusion
- Assess methodological differences — Conflicting results often stem from differences in dose, form, duration, population, or outcome measures; we identify these where possible
- Weight by study quality — A well-designed RCT with 200 participants carries more weight than a pilot study with 15 participants, even if their conclusions differ
- Note funding patterns — If positive studies are predominantly manufacturer-funded and negative studies are independently funded (or vice versa), we note this pattern
- Avoid false resolution — We do not force a clean conclusion when the evidence genuinely conflicts. We state the disagreement and let readers understand the uncertainty
Step 6: Plain-Language Reporting
Clinical studies are written for other researchers. Our job is to translate them for everyone else without distorting what they found. We follow these principles:
- Use the study’s own language for findings — We do not upgrade “may improve” to “improves” or “preliminary evidence suggests” to “research proves”
- State limitations alongside findings — If a positive result came from a 20-person, manufacturer-funded study with no placebo control, we say that
- Distinguish types of evidence — Cell studies, animal studies, and human studies are clearly labeled as such
- Distinguish delivery methods — Topical application studies are not cited as evidence for oral supplement efficacy
- Avoid false precision — We do not present ranges or general findings as exact numbers unless the study reported them that way
- Explain practical implications — Where possible, we explain what a finding might mean for a consumer considering the ingredient
Step 7: Limitation Disclosure
Every ingredient evidence review and study summary on this site includes explicit disclosure of:
- The limitations of the studies cited
- What the evidence does not prove
- What remains unknown or insufficiently studied
- Whether the evidence is from ingredient-level research or finished-product testing
- Whether the studied dose, form, and duration match what is commonly available in consumer products
- Any disclosed funding sources or author conflicts of interest
We believe that telling you what we do not know is just as important as telling you what we do know. An honest assessment of the limits of current skin supplement research is essential for making informed decisions about these products.
Step 8: Review and Updates
Research on skin supplement ingredients is active and evolving. New studies are published, existing studies are retracted or corrected, and the scientific understanding of nutrient-skin interactions continues to develop. We maintain our content through:
- Scheduled reviews — High-interest ingredient pages are reviewed at minimum every 180 days; educational content every 365 days
- Triggered updates — Study retractions, major new meta-analyses, or regulatory safety alerts prompt immediate review
- Correction transparency — All corrections are noted with dates and described on the affected page
What Our Methodology Cannot Do
Our research methodology is designed to produce accurate, transparent summaries of available clinical evidence on skin supplement ingredients. It is not a substitute for systematic reviews conducted by research institutions, regulatory assessments by agencies like the FDA or EFSA, clinical judgment by a dermatologist, or individualized medical guidance from a qualified healthcare provider. We present the published evidence as clearly as we can. What you do with that information is a decision best made with the help of someone who knows your health situation and skin concerns.
For questions about our methodology or to suggest improvements, visit our Contact page.